May 12, 2025 - 22:08

In a recent corporate update, Black Diamond Therapeutics revealed significant advancements in its clinical trials and financial standing for the first quarter of 2025. The company is on track to present clinical data from its Phase 2 trial of BDTX-1535, targeting first-line patients with non-classical EGFR mutations in non-small cell lung cancer (NSCLC), with results expected in the fourth quarter of 2025.
Additionally, the company has initiated an expansion of its investigator-sponsored Phase 0/1 trial, focusing on newly diagnosed glioblastoma patients with EGFR alterations. This expansion commenced in the first quarter of 2025, reflecting the company’s commitment to exploring innovative treatment options for challenging cancers.
Financially, Black Diamond Therapeutics reported cash, cash equivalents, and investments totaling $152.4 million as of March 31, 2025. This financial position is anticipated to adequately support the company’s operations through to the fourth quarter of 2027, ensuring continued progress in its clinical and research endeavors.
October 14, 2026 - 00:16
Bank of America Slapped with $1.2 Billion Fine for Money Laundering FailuresFederal regulators have imposed a hefty penalty on Bank of America, ordering the financial giant to pay over $1.2 billion for shortcomings in its anti-money laundering controls. The fine, announced...
October 13, 2026 - 02:12
GAC Connects with Europe Through Engineering and Football at 2026 Paris Motor ShowThe 91st Paris Motor Show opened on October 12 at Paris Expo Porte de Versailles, where one Chinese manufacturer made its presence felt with a mix of technology and sport. The company displayed...
October 12, 2026 - 17:30
Sector Update: Financial Stocks Advance Late AfternoonFinancial sector stocks moved higher in the final hours of Monday`s trading session, recovering from a sluggish start to the day. The NYSE Financial Index climbed 0.5%, reflecting renewed buying...
October 12, 2026 - 02:39
Washington Warns Kyiv Over Refinery Strikes As Envoy Pushes European CapitalsAmerican officials have signaled they could cut off a key weapons pipeline to Ukraine if long range strikes on Russian oil infrastructure continue, according to people familiar with the discussions...